Sponsor Pipeline

New Cancer Cure-Bio Co.,Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07114861 The KN510713 Study in Combination With mFOLFIRINOX Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Recruiting
Disease Areas
Pancreatic Cancer (1)
Get alerts when New Cancer Cure-Bio Co.,Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free